Overview
Charles Drake is an Oncologist and a Hematologist Oncology provider in New York, New York. Dr. Drake is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Prostatectomy.
His clinical research consists of co-authoring 252 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 35 articles and participated in 2 clinical trials in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
622 W 168th St, New York, NY 10032
161 Fort Washington Ave, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Memorial Solid Tumor Group
Robert Motzer is an Oncologist in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy.
Memorial Solid Tumor Group
Martin Voss is an Oncologist in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
Memorial Solid Tumor Group
Ritesh Kotecha is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Kotecha is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Prostate Cancer, and Nephrectomy. Dr. Kotecha is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Drake isElite. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)
- Distinguished
- Bladder CancerDr. Drake isDistinguished. Learn about Bladder Cancer.
- Advanced
- AstrocytomaDr. Drake isAdvanced. Learn about Astrocytoma.
- Familial Prostate CancerDr. Drake isAdvanced. Learn about Familial Prostate Cancer.
- GlioblastomaDr. Drake isAdvanced. Learn about Glioblastoma.
- GliomaDr. Drake isAdvanced. Learn about Glioma.
- Gliomatosis CerebriDr. Drake isAdvanced. Learn about Gliomatosis Cerebri.
- MelanomaDr. Drake isAdvanced. Learn about Melanoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Drake isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Drake isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Drake isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Drake isExperienced. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaDr. Drake isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Drake isExperienced. Learn about Clear Cell Sarcoma.